Filing Flows › Elanco Animal Health (ELAN) › Q3 2025
Elanco Animal Health (ELAN) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 5, 2025
Elanco Animal Health (ELAN) reported revenue of $1.1B for the third quarter 2025 (Q3 2025), +10% from a year earlier and -8% from the quarter before. Operating margin was -4.4%, net loss $34.0M (3.0% of revenue).
Elanco Animal Health, Q3 2025: revenue $1.1B (+10% year over year), operating margin -4.4%, net loss $34.0M, operating cash flow $219M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1B | -8% | +10% |
| Operating profit | −$50.0M | -300% | — |
| Net earnings | −$34.0M | -409% | — |
| Operating cash flow | $219M | -8% | +35% |
| Free cash flow | $127M | -29% | +6% |
What changed
Revenue was $1.1B in Q3 2025, up 10% year over year and down 8% from the previous quarter. Pet Health was the largest line at 47% of revenue. Pet Health added $0.05B year over year (up 10%), 44% of the total change. Contract Manufacturing declined 21%.
Gross margin was 53.4%, up 1.2 points from a year earlier. Operating costs exceeded revenue by $0.05B, an operating margin of -4.4%. The quarter ended with a net loss of $0.03B, after a profit of $0.01B the previous quarter.
Operating cash flow was $0.22B (up 35% year over year). Non-cash charges added back $0.18B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.06B. Capital expenditures of $0.09B left free cash flow of $0.13B.
Questions
What was Elanco Animal Health's revenue in the third quarter 2025?
Elanco Animal Health (ELAN) reported revenue of $1.1B for the third quarter 2025 (Q3 2025), +10% from a year earlier and -8% from the quarter before.
Was Elanco Animal Health profitable in the third quarter 2025?
Operating loss was $50.0M (-4.4% of revenue) and net loss $34.0M.